DHR vs HD: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Home Depot, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
The Home Depot, Inc. · Consumer Cyclical
$334.28
+34.7% upside to fair value
Grade A
High Quality
QuantHub Verdict
HD has more upside to fair value
(+34.7%).
HD trades at a lower forward P/E
(23.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
HD |
| Current Price |
$177.17 |
$334.28 |
| Fair Value Estimate |
$192.90 |
$450.15 |
| Upside to Fair Value |
+8.9%
|
+34.7%
|
| Market Cap |
$125.4B |
$333.3B |
| Forward P/E |
34.1x
|
23.7x
|
| EV / EBITDA |
20.8x
|
16.1x
|
| Price / Sales |
5.1x
|
2.0x
|
| Price / FCF |
23.7x
|
23.3x
|
| Revenue Growth YoY |
+3.7%
|
+4.8%
|
| Gross Margin |
60.7%
|
33.1%
|
| Operating Margin |
21.0%
|
12.4%
|
| Return on Equity |
7.1%
|
113.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
The Home Depot, Inc. is the leading U.S. home improvement retailer with a dominant market share of approximately 47 to 50 percent, significantly ahead of Lowe's at 17 to 19 percent. The company benefits from a durable competitive moat driven by scale, a robust supply chain, and a pro-customer infrastructure. Its management team is composed of long-tenured insiders, including CEO Ted Decker who ha…
Accumulation Zones
| Metric |
DHR |
HD |
| Zone Low |
$144.68 |
$337.61 |
| Zone High |
$163.97 |
$382.63 |
| In Buy Zone? |
No
|
Yes
|